Results 281 to 290 of about 9,137,637 (404)
Pharmaceutical Funding Reforms: Proposed Introduction of the Pharmaceutical Benefits Scheme into Public Hospitals [PDF]
Yvonne M Allinson
openalex +1 more source
Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment
A novel orally drug‐probiotic co‐delivery system designated as Rh‐YBS for UC treatment, which highlights three innovations: (i) YPs involves colonic submucosa delivery via M cells; (ii) Rh (drug) promotes the colonization and growth of BS (probiotic) in the colon.
Lingqiang Li+21 more
wiley +1 more source
Did the reform of the public hospitals' pay system increase the physicians' pay in China? A cross-sectional study. [PDF]
Zhao Y+5 more
europepmc +1 more source
Public and private hospitals in Bangladesh: service quality and predictors of hospital choice [PDF]
Syed Saad Andaleeb
openalex +1 more source
Midkine (MDK) is a mediator of the interaction between pancreatic cancer and beta cells. MDK, which originated from pancreatic ductal adenocarcinoma cells, exerted deleterious effects on paraneoplastic beta cells by binding to the SDC4 receptor on the beta cell surface and subsequently downregulating the Ras signaling pathway, thereby impairing insulin
Zengyu Feng+7 more
wiley +1 more source
Copayment and utilization of publicly insured hospital services in Saskatchewan.
John K. Horne
openalex +2 more sources
This study constructs a stacked multimodal machine learning model for nonalcoholic fattly liver disease (NAFLD) by integrating genetic and clinical features, and synthesize an in‐silico quantitative marker (ISNLD) that enables personalized risk stratification for intrahepatic and extrahepatic outcomes of high‐risk individuals of NAFLD.
Lushan Xiao+14 more
wiley +1 more source
Determinants of stillbirth among women who gave birth in public hospitals in Northwest Ethiopia, 2022. [PDF]
Melaku AG+6 more
europepmc +1 more source
Market Forces and the Public Good: Competition Among Hospitals and Provision of Indigent Care
Richard G. Frank+2 more
openalex +1 more source
This study identifies a novel oncogenic role and a previously unrecognized phosphorylation substrate of BCKDK in RCC, wherein it promotes tumor progression and drug resistance through AKT phosphorylation at both Thr308 and Ser473 sites and activation of AKT/mTOR and AKT/ABCB1 signaling pathways, offering a promising prognostic marker and therapeutic ...
Qin Tian+18 more
wiley +1 more source